SCHEMBL1008703

SCHEMBL1008703

C1=CC(=Nc2ccccc2)NC(=Nc2ccccc2)C1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ KMT2A Q03164 4/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ MAPT P10636 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ NPC1 O15118 3/20 0.34
▸ IDO1 P14902 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32
▸ GSK3B P49841 2/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1008702 1.00 ATM (0.42) ATML3MBTL1KMT2AMEN1MAPT
Hydrochloric Acid SCHEMBL15949978 0.70 USP2 (0.42) L3MBTL1KMT2AMEN1MAPTGAA
SCHEMBL3224077 0.66 ATM (0.48) ATML3MBTL1KMT2AMEN1MAPT
SCHEMBL3224073 0.66 ATM (0.48) ATML3MBTL1KMT2AMEN1MAPT
SCHEMBL2540740 0.66 ATM (0.41) ATML3MBTL1KMT2AMEN1MAPT
SCHEMBL18544020 0.61 ATM (0.37) ATML3MBTL1KMT2AMEN1MAPT
SCHEMBL7866209 0.59 CYP2D6 (0.34) KMT2AMEN1MAPTCYP2C19IDO1
SCHEMBL20042575 0.59 NPC1 (0.48) ATML3MBTL1KMT2AMEN1MAPT
SCHEMBL20360735 0.59 ATM (1.00) ATML3MBTL1KMT2AMEN1MAPT
SCHEMBL9615422 0.59 LMNA (0.33) ATML3MBTL1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575056-B2 Method of preparing a catalytic composition for dimerization, co-dimerization and oligomerization of olefins IFP Energies Nouvelles (FR) 2013-11-05 — — US disclosed
US-20110009581-A1 METHOD OF PREPARING A CATALYTIC COMPOSITION FOR DIMERIZATION, CO-DIMERIZATION AND OLIGOMERIZATION OF OLEFINS IFP (FR) 2011-01-13 — — US disclosed
EP-2234722-A1 METHOD FOR PREPARING A CATALYTIC COMPOSITION FOR THE DIMERIZATION, CO DIMERIZATION AND OLIGOMERIZATION OF OLEFINS IFP Energies nouvelles (FR) 2010-10-06 — — EP disclosed
WO-2009103877-A1 METHOD FOR PREPARING A CATALYTIC COMPOSITION FOR THE DIMERIZATION, CO‑DIMERIZATION AND OLIGOMERIZATION OF OLEFINS IFP (FR) 2009-08-27 — — WO disclosed
US-7429684-B2 Process for oligomerization of ethylene to linear α-olefins EXXONMOBILE RESEARCH AND ENGINEERING COMPANY (US) 2008-09-30 — — US disclosed
US-20050192470-A1 Process for oligomerization of ethylene to linear alpha-olefins EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2005-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192470-A1 Process for oligomerization of ethylene to linear alpha-olefins SNCA, PPOX, HMOX1 ATM 2949/4885L3MBTL1 2475/4885KMT2A 4037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback